← SynDRA
FEXAGRATINIB
SynDRA canonical compound SYN0038107 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Primary target(s) | FGF2 | FGFR1 | FGFR2 | FGFR3 | FGFR4 | IGF1R | KDR |
| Mechanism of action | FGFR inhibitor |
All known targets
- FGFR1
- FGFR2
- FGFR3
- FGFR4
- FGF2
- IGF1R
- KDR
Mechanisms of action (all sources)
- FGFR3 INHIBITOR
- Fibroblast growth factor receptor inhibitor
- FGFR1 INHIBITOR
- FGFR4 INHIBITOR
- FGFR2 INHIBITOR
- FGFR inhibitor
- FGFR1 MODULATOR
Cross-references
Synonyms
- AZD-4547
- AZD4547
- 66T
- ABSK-091
- ABSK091
- ADSK091
- KB-74810
- AZD 4547
- UNII-2167OG1EKJ
- 2167OG1EKJ
- CHEBI:63453
- N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-rel-3,5-dimethylpiperazin-1-yl)benzamide
- N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-(cis-3,5-dimethylpiperazin-1-yl)benzamide
- rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide
- N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide
- N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide
- N-{3-[2-(3,5-Dimethoxyphenyl)ethyl]-1h-Pyrazol-5-Yl}-4-[(3r,5s)-3,5-Dimethylpiperazin-1-Yl]benzamide
- N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide
- SCHEMBL63884
- GTPL7707
- SCHEMBL15250892
- DTXSID80145887
- AZD 4547 [WHO-DD]
- AMY16612
- EX-A1578
- MFCD22580423
- NSC764239
- NSC765338
- NSC799346
- s2801
- ZINC95616598
- AKOS024464898
- BCP9000364
- CCG-269382
- CS-0971
- DB12247
- NSC-764239
- NSC-765338
- NSC-799346
Look up FEXAGRATINIB in the interactive SynDRA portal →